Loss of maternally derived measles immunity in Argentinian infants

Pediatric Infectious Disease Journal

Volumn 17, Issue 4, 1998, Pages 313-316

  Nates, Silvia V ^a,c   Giordano, Miguel O ^a   Medeot, Silvia I ^a   Martinez, Laura C ^a   Baudagna, Ana M ^b   Naretto, Elizabeth ^b   Garrido, Patricia ^a   De Wolff, Cristina D ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Ministerio de Salud y Acción Social de la Nation CDW   (Argentina)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Maternal measles antibody; Measles; Measles immunity

Indexed keywords

MATERNAL ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE;

ANTIBODY DETECTION; ANTIBODY TITER; ARGENTINA; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INFANT; INFANT DISEASE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; NEWBORN; PRIORITY JOURNAL; SEROPREVALENCE;

EID: 0031969893     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199804000-00009     Document Type: Article

References (18)

1. World Health Organization. EPI for the 1990s. Publication WHO/EPI/GEN/92.2. Geneva: World Health Organization, 1992.
2. Boletm Informativo. Ministerio de Salud y Acción Social. Republica Argentina. June 28,1993, No. 27, Tomo 12, Ano 12.
3. Albrecht P, Ennis FA, Satzman EJ, Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr 1977;91:715-22.
4. Felicity T, Cutts J, Markowitz L. Successes and failures in measles control. J Infect Dis 1994;170(Suppl 1):S32-41.
5. Expanded Programme on Immunization. Measles immunization. Wkly Epidemiol Rec 1979;54:337-9.
6. Nates SV, Key GY, Giordano MO, Zapata MT, Depetris AR, Boshell J. Modified seroneutralization assay for measles virus antibody detection. Res Virol 1994; 145:45-9.
7. Bishop YM, Fienberg SE, Holland PW. Discrete multivariate analysis: theory and practice. Cambridge, MA: MIT Press, 1975.
8. Halsey NA, Boulos R, Mode F. Response to measles vaccine in Haitian infants 6 to 12 months old: influence of maternal antibodies, malnutrition and concurrent illness. N Engl J Med 1985;313:544-9.
9. Ministries of Health of Brazil, Chile, Costa Rica, Ecuador and Pan American Health Organization. Seroconversion rates and measles antibody titre induced by measles vaccine in Latin American children. Bull Pan Am Health Organ 1982; 16:272-85.
10. Dagan R, Stater PE, Duvdevani P, Goluvev N, Mendelson E. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel. Pediatr Infect Dis J 1995;14:965-9.
11. Dabis F, Waldman RJ, Mann GF, Commenges D, Madzoud G, Jones ST. Loss of maternal measles antibody during infancy in an African city. Int J Epidemiol 1989;18:264-8.
12. Maldonado YA, Lawrence EC, Dehovitz BA, Hartzell H, Albrecht P. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 1995; 96:447-50.
13. Markowitz LE, Preblud SR, Fine PEM, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990;9:101-10.
14. Black FL. Measles active and passive immunity in a worldwide perspective. Prog Med Virol 1989;36:1-33.
15. Jenks PJ, Caul EO, Roome APCH. Maternally derived measles immunity in children of naturally infected and vaccinated mothers. Epidemiol Infect 1988;101:473-6.
16. Lennon JL, Black FL. Maternally derived measles immunity in era of vaccine protected mothers. J Pediatr 1986;108(Part l):671-6.
17. Pabst HF, Spady DW, Marusyk RG, et al. Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J 1992;11:525-9.
18. Bromberg K, Shah B, Clark-Golden M, et al. Maternal immnunity to measles and infant immunity at less than twelve months of age relative to maternal place of birth. J Pediatr 1995;125:579-81.